CIK: 0001594912
Total reported value
$29.2M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics Inc-class A | Stock-Other | 95.85% | — | -3.66% | |
| 2 | EPZMEUR | Epizyme INC | Stock-Other | 1.38% | — | -35.74% | |
| 3 | INSM | Insmed INC | Stock-Healthcare | 0.89% | — | -73.12% | |
| 4 | AERIEUR | Aerie Pharmaceuticals INC | Stock-Other | 0.80% | — | -84.83% | |
| 5 | XLRN | Acceleron Pharma INC | Stock-Other | 0.73% | — | -81.56% | |
| 6 | RGNX | Regenxbio INC | Stock-Other | 0.36% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics Inc-class A | +10% | -3.66% | Trim |
| 2 | XLRN | Acceleron Pharma INC | -0.9% | -81.56% | Trim |
| 3 | EPZMEUR | Epizyme INC | -1% | -35.74% | Trim |
| 4 | INSM | Insmed INC | -2.6% | -73.12% | Trim |
| 5 | AERIEUR | Aerie Pharmaceuticals INC | -5.9% | -84.83% | Trim |
| 6 | RGNX | Regenxbio INC | — | NEW | New buy |